5,172 transcripts
Page 8 of 100
6fd
Earnings call transcript
NASDAQ
2024 Q3
14 Aug 24
our predictions. You should also review our most recent Form 10-K and 10-Q 4 for a more complete discussion of these factors and other risks
77
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
section of Movano Health's filings with the Securities and Exchange Commission, specifically the company's Forms 10-Q and 10-K. Except as otherwise
nakr
Earnings call transcript
NASDAQ
2025 Q1
14 Aug 24
filings, including, but not limited to, its annual report on the Form 10-K and quarterly reports for Form 10-Q.
Any forward-looking statements made
nxz
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
results and business, please refer to the disclosure in today's earnings release and on our most recent Form 10-Q and 10-K and other reports that we may
3h
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
and other disclosures contained in Vivos' filing with the Securities and Exchange Commission, including the risk factors and other disclosures in our Form 10
fq
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
Commission, which include, among other things, our Forms 10-Q and 10-K. All of our projections and other forward-looking statements represent our judgment
jov
Earnings call transcript
OTC
2024 Q2
14 Aug 24
materially.
Please refer to the documents filed by the company from time to time with the SEC, and in particular, its most recently Form 10-K. Those
ee
Earnings call transcript
OTC
2024 Q2
14 Aug 24
-looking statements. A detailed discussion of such risks and uncertainties are contained in our most recent Form 10-K, 10-Q and other reports filed
g7ml
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
in STRATA Skin Sciences' most recently filed annual report on Form 10-K and subsequent periodic reports filed with the SEC and STRATA Skin Sciences
6x
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
, including its annual report on Form 10-K and the quarterly reports on Form 10-Q and current reports on Form 8-K, including any warnings, risk factors
54o
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
in the forward-looking statements, see Tivic Health's filings with the SEC, including its annual report on Form 10-K for the year ended December 31
y8gr
Earnings call transcript
NASDAQ
2025 Q1
14 Aug 24
Factors, in the company's annual report on Form 10-K for the fiscal year ended March 31, 2024, the company's most recent quarterly report on Form 10-Q
cw
Earnings call transcript
NASDAQ
2024 Q4
14 Aug 24
to the risks and uncertainties that we discuss in detail in our documents filed with the SEC, specifically the most recent report on Forms 10-K and 10-Q
y1
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
those discussed in the Risk Factors section of the company's annual report on Form 10-K filed with the SEC on March 29, 2024.
In particular
qdc1
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
our predictions. You should also review our most recent Form 10-K and Form 10-Q for a more complete discussion of these factors and other risks
t5e
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
in scPharmaceuticals' Annual Report on Form 10-K, quarterly reports on Form 10-Q and other reports filed by the company with the SEC to which your
vrc
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
for the quarter ended June 30, 2024, annual reports on Form 10-K and current reports on Form 8-K filed with the Securities and Exchange Commission
qxkc
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
. These forward-looking statements are subject to various risks, uncertainties and assumptions as described in the company's Form 10-K filed
idt
Earnings call transcript
NASDAQ
2024 Q2
14 Aug 24
listed from time to time in our annual reports on Form 10-K, quarterly reports on Form 10-Q and any other SEC filings.
The company undertakes
77d1
Earnings call transcript
OTC
2024 Q2
14 Aug 24
with the Securities and Exchange Commission, including the risk factors and other disclosures in our Form 10-K and other filings with the SEC. All